JUNO

Juno Theraputics

NASDAQ

Add Alert

JUNO

Juno Theraputics

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

JJSimmons

01/25/18 10:31 AM

Post #279

Re: #276: @SirCharChar - WOO HOO!!!! THANK YOU JUNO!!!

Still holding up. Very good sign!

JJSimmons

01/24/18 4:56 PM

Post #278

Re: #276: @SirCharChar - WOO HOO!!!! THANK YOU JUNO!!!

Love how it held up. Normally these sell off after big days.

JJSimmons

01/23/18 8:14 AM

Post #277

Re: #276: @SirCharChar - WOO HOO!!!! THANK YOU JUNO!!!

No kidding. I bought back in September and have doubled my money.

SirCharChar Free

01/22/18 9:57 AM

Post #276

WOO HOO!!!! THANK YOU JUNO!!!

Awl416

01/22/18 8:16 AM

Post #275

Re: #272: @T695 - Wow, do you know the offer price?

Announced today - 9b / $87

stockstalk09 Free

01/17/18 8:32 AM

Post #274

Re: #266: @zerowinner - Someone bought 1000 May 2018 $85 calls for

I think someone just figured out why, a little front loading tipster caught some wind back then, but seems to have been a bit off on what strike price to pick, if they did get a leak, with what ever they make, they can request the SEC and Fed's to incrust diamonds into the handcuffs when they come to take them for a ride downtown.

Talc Moan

01/17/18 8:05 AM

Post #273

Re: #272: @T695 - Wow, do you know the offer price?

Not sure just saw it on the news yesterday.

T695

01/17/18 8:00 AM

Post #272

Re: #271: @Talc Moan - What a jump on Celgene buyout talks JUNO

Wow, do you know the offer price?

Talc Moan

01/16/18 5:23 PM

Post #271

What a jump on Celgene buyout talks

JUNO

north40000 PremiumMember

12/14/17 8:12 AM

Post #270

Re: #269: @jr881 - JUNO is also working on SOLID tumors with

MSKCC/PPHM poster # 1651 at AACR in April 2017 highlights safety in pre-clinical CAR-T studies. Note conclusions.

jr881

12/12/17 7:31 PM

Post #269

JUNO is also working on SOLID tumors with their Car T model.This down the road will be a larger market and change the way we treat cancer.

ITMS

12/12/17 2:45 PM

Post #268

$JUNO Hits Support For Technical Bounce Trade Here...

Shares of Juno Therapeutics Inc (NASDAQ:JUNO) have fallen sharply over the last two trading days. On a technical basis, the biotech hit major support when it broke through $46.00. This is a bounce level for investors looking for a quick couple day bounce. Look for a snap back to $50 in the coming days.

Gareth Soloway
InTheMoneyStocks

stocktrademan Free

12/02/17 12:54 PM

Post #267

JUNO buy 56.70

normal chart

log chart

zerowinner Free

11/07/17 1:17 PM

Post #266

Someone bought 1000 May 2018 $85 calls for about $2.15anyone have a clue why?

Easymoneyman00 Free

11/05/17 3:30 PM

Post #265

Re: #263: @SirCharChar - Climb baby! Climb higher!

Sir char char, how many deaths has JUNO had during these trials? Very toxic stuff ! I hope they don't try and cover up anymore deaths . They sure forgot to mention the last 2 they had until they were called out on it? Good Luck just can't believe they went to $20 and are now at close to $60 with so many deaths caused by there treatment? Crazy!

girlfriend Free

11/02/17 12:43 PM

Post #264

Re: #263: @SirCharChar - Climb baby! Climb higher!

$56.12 is where I got 2/3 out here!

SirCharChar Free

11/01/17 9:54 AM

Post #263

Climb baby! Climb higher!

Stockstrodamus Free

10/25/17 9:37 AM

Post #262

My guess is that JUNO will slowly creep to 47.04. Then will test Friday.

Stockstrodamus Free

10/24/17 8:58 AM

Post #261

Run baby run

girlfriend Free

10/23/17 12:18 PM

Post #260

Re: #259: @Stockstrodamus - JUNOOOOOOOOOO!!!! $$$$$ BUY BUY BUY BUY

JUNO at 45.40 here trying to breakout of its recent 41-45 channel. Lets go!

Stockstrodamus Free

10/23/17 11:19 AM

Post #259

JUNOOOOOOOOOO!!!!

$$$$$

BUY BUY BUY BUY

SirCharChar Free

09/13/17 7:34 PM

Post #258

So much going on and this board is dead. The future looks so bright.

Avispa

08/29/17 10:32 AM

Post #257

https://seekingalpha.com/news/3292381-buying-continues-juno-therapeutics-shares-16-percent

moniluv

02/16/17 9:38 AM

Post #256

There's a gap that needs to be filled...not sure when another PR will be out tho.

buckmaster6985 Free

02/15/17 3:57 PM

Post #255

Re: #254: @DONTSELLFROM_FEAR - MACD FORMS BULLISH CROSSOVER RSI LOW ADX

I'm up over a grand in this stock. Should I time it or hold longer?

DONTSELLFROM_FEAR Free

12/23/16 3:56 PM

Post #254

MACD FORMS BULLISH CROSSOVER RSI LOW ADX SHOWS STRONG TREND..COULD HIT 25.00 SOON

Hypi

11/28/16 7:46 PM

Post #253

I hate to gloat, but told you so about this being done.

stocktrademan Free

11/27/16 6:15 PM

Post #252

JUNO bearish 23.01

ANIA77

11/23/16 12:28 PM

Post #251

Re: #250: @T695 - This going down a lot further IMO

Yeah I agree. All these bio ticks usually get hit by a wave of class lawsuits shortly after bad news.. which usually causes additional panic on market and father drop in pps. My bid is lower.
JUNO

T695

11/23/16 11:15 AM

Post #250

This going down a lot further IMO

T695

11/23/16 11:13 AM

Post #249

Re: #248: @ANIA77 - JUNO could be a good buy here.. Though it's

Two more patients died, I would wait awhile to let that soak in before buying

ANIA77

11/23/16 9:35 AM

Post #248

Re: #247: @MARINO - Marino was wrong. Not $30 but $33 this week

JUNO could be a good buy here..
Though it's possible it will dip below $20 when lawsuits start hitting wires again soon
Have a bid in..
JUNO

MARINO

09/07/16 10:51 PM

Post #247

Marino was wrong. Not $30 but $33 this week

DITRstocks Free

09/07/16 4:10 PM

Post #246

boom

MARINO

09/05/16 10:13 PM

Post #245

JUNO easy $30 this week

MARINO

09/02/16 6:51 PM

Post #244

Marino in today at $28.40

TREND1

07/28/16 10:20 PM

Post #243

JUNO DAY

ANIA77

07/26/16 11:27 AM

Post #242

Re: #238: @TREND1 - Thanks

Juno on fire

growacet

07/22/16 12:06 AM

Post #241

Sorry for the dupe...double clutched

growacet

07/22/16 12:05 AM

Post #240

Blog post on JUNO lawsuit....

Asks the question: Is Ziopharm next? Also mentions KITE:

http://www.avoidthebag.com/2016/07/juno-therapeutics-being-sued-is.html

Hypi

07/19/16 7:53 AM

Post #239

CELG looking at alternative approaches and do realize there is no exact science. As TREND1 says about other stocks I own or follow "stock price tells the story." The same could be said for JUNO.

http://www.fiercebiotech.com/biotech/jounce-nabs-first-big-deal-2-6b-i-o-tie-up-celgene

Still like the technology just not sure I like this particular company. Typical biotech huge risk, but huge reward potential. No position, but watching closely for possible entry.

TREND1

07/17/16 1:35 AM

Post #238

Re: #237: @ANIA77 - "Our JCAR017 plans remain on track. We expect

Thanks

ANIA77

07/17/16 12:26 AM

Post #237

Re: #226: @TREND1 - Phase 3 completion date?

"Our JCAR017 plans remain on track. We expect to be able to have our first approval in the United States as early as 2018," Bishop said."

"Although we have experienced a setback in the ROCKET trial with the clinical hold…we are optimistic that we will achieve results comparable to those in the phase I trial. These results should provide the basis for an accelerated approval," according to Bishop."

JUNO

Hypi

07/16/16 11:32 AM

Post #236

Re: #235: @TREND1 - *****AML Therapies: Seattle Genetics Vs. GlycoMimetics

No current position, but did have some puts when it tanked from $42 to $28 on PhaseII trial halt and I sold them at that time. I'm actually looking to get back in long, but was thinking we might see previous lows in the $22-$24 range. Probably missed that one, but a believer in the technology.

I only bought puts because I thought it was overvalued and felt the IBB was under pressure 2-3 weeks ago. Now the market if making new highs (though I'm not sold on a break out of the indexes that have transpired in the last week. Sitting and watching for the time being.

TREND1

07/16/16 11:08 AM

Post #235

*****AML Therapies: Seattle Genetics Vs. GlycoMimetics

ALSO JUNO MENTIONED

Jul. 15, 2016 8:10 AM ET
About: GlycoMimetics (GLYC), SGEN, Includes: JUNO

William Meyers
Follow (1,085 followers)

Long only, tech, biotech, research analyst

Summary

•Acute Myeloid Leukemia is very difficult to treat successfully.

•Seattle Genetics SGN-CD33A started a Phase 3 trial.

•GlycoMimetics GMI-1271 started Phase 2 trial.

•There are other competitors, but it is unlikely AML will be 100% cured by any one therapy.

http://seekingalpha.com/article/3988622-aml-therapies-seattle-genetics-vs-glycomimetics?ifp=0&app=1

TREND1

07/15/16 5:59 PM

Post #234

Re: #218: @Hypi - Something smells here and in this whole space

Hypi JUNO is working on a product that does not exist.

That is why 3 people (all under 25) can die, but the FDA still approves
resumption of phase 2 trial.

It will save lives when approved.

TREND1

07/15/16 3:26 PM

Post #233

***** JUNO WEEKLY NICE ACTING STOCK TO WEEKLY TREND LINES.

ANIA77

07/15/16 2:33 PM

Post #232

Re: #230: @TREND1 - Juno buys early-stage biotech for access to immuno-oncology

Great news. It should bounce to $34 next week imo
JUNO

TREND1

07/15/16 2:22 PM

Post #231

***** JUNO 1 HOUR CLOSES

TREND1

07/15/16 12:44 PM

Post #230

Juno buys early-stage biotech for access to immuno-oncology candidate

Jul 14 2016, 16:32 ET | About: Juno Therapeutics (JUNO) | By: Douglas W. House, SA News Editor

http://seekingalpha.com/news/3193337-juno-buys-early-stage-biotech-access-immuno-oncology-candidate